R. Uotila

Let's get cracking- nut allergy diagnostics and peanut oral immunotherapy

R. Uotila, 2018 .

Double‐blind placebo‐controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation

M. Mäkelä, L. P. Malmberg, A. Pelkonen, 2017, Acta paediatrica.

Cross‐sensitization profiles of edible nuts in a birch‐endemic area

M. Mäkelä, A. Pelkonen, A. Kukkonen, 2016, Allergy.

Peanut oral immunotherapy increases IgG4 to Ara h 1, 2, and 6 but does not affect IgG4 to other allergens

D. Greco, M. Mäkelä, A. Pelkonen, 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Component‐resolved diagnostics demonstrates that most peanut‐allergic individuals could potentially introduce tree nuts to their diet

M. Mäkelä, B. Remington, W. Blom, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens.

D. Greco, M. Mäkelä, A. Pelkonen, 2017, The Journal of allergy and clinical immunology.

Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens.

M. Mäkelä, A. Pelkonen, A. Kukkonen, 2017, The Journal of allergy and clinical immunology.